Retour sur lavenir.net
   LOTUS BAKERIES 9 940.000 € (+0,40 %)     VASTNED 29.700 € (+0,34 %)     INCLUSIO SA/NV 17.600 € (+0,28 %)     TUBIZE-FIN 219.500 € (+0,69 %)     UCB 264.500 € (-1,23 %)     ARGENX SE 647.200 € (+0,22 %)     RETAIL ESTATES 68.300 € (+1,79 %)     WDP 23.480 € (+0,77 %)     SOLVAY 26.700 € (-0,15 %)     ASCENCIO 49.800 € (+2,26 %)     VGP 86.900 € (0,00 %)     EXMAR 10.140 € (+1,00 %)     UMICORE 16.350 € (-1,39 %)     NYXOAH 3.040 € (+13,64 %)     EKOPAK 4.600 € (-5,93 %)     QUESTFOR GR-PRICAF 2.810 € (-1,40 %)     WERELDHAVE BELGIUM 55.000 € (+0,73 %)     JENSEN-GROUP 66.200 € (-1,19 %)     SIPEF 97.800 € (+0,41 %)     SOFINA 214.200 € (-0,28 %)     WHAT''S COOKING GP 142.000 € (+0,71 %)     ONWARD MEDICAL 3.235 € (-5,27 %)     D'IETEREN GROUP 161.700 € (-1,76 %)     CAMPINE 198.000 € (+1,54 %)     TINC 11.720 € (+0,69 %)     KBC 108.700 € (-1,05 %)     DEME GROUP 190.000 € (-0,52 %)     AB INBEV 61.500 € (+1,25 %)     MELEXIS 54.050 € (-1,46 %)     DECEUNINCK 2.045 € (-0,97 %)     FAGRON 22.100 € (+1,38 %)     RECTICEL 9.620 € (-2,04 %)     CENERGY 19.240 € (-1,33 %)     AZELIS GROUP 8.935 € (+2,00 %)     COFINIMMO 83.900 € (+0,66 %)     SYENSQO 47.540 € (-3,59 %)     KBC ANCORA 72.500 € (-0,68 %)     EVS BROADC.EQUIPM. 33.750 € (-1,46 %)     GIMV 46.200 € (+1,09 %)     FLUXYS BELGIUM D 20.900 € (-2,79 %)     PROXIMUS 6.985 € (-1,48 %)     KINEPOLIS GROUP 26.600 € (+0,38 %)     ACKERMANS V.HAAREN 272.200 € (+0,37 %)     MONTEA 67.400 € (+0,30 %)     ELIA GROUP 135.000 € (+0,75 %)     SHURGARD 25.750 € (+0,39 %)     BEKAERT 39.750 € (-2,09 %)     ONTEX GROUP 3.345 € (+0,60 %)     ENERGYVISION 12.500 € (+0,24 %)     COLRUYT 35.660 € (+0,96 %)     VIOHALCO 12.780 € (-3,18 %)     ORANGE BELGIUM 20.500 € (0,00 %)     BARCO 9.315 € (-2,10 %)     CFE 10.500 € (0,00 %)     IMMOBEL 21.800 € (+1,40 %)     SOLVAC NOM(RETAIL) 68.400 € (+0,88 %)     TESSENDERLO 20.500 € (-0,73 %)     XIOR 27.400 € (+1,86 %)     HOME INVEST BE. 19.100 € (+3,35 %)     ECONOCOM GROUP 1.400 € (-1,13 %)  
   SANOFI 82.580 € (-0,35 %)     ID LOGISTICS GROUP 325.500 € (-2,54 %)     EVERGREEN 0.170 € (+129,05 %)     VALEO 10.400 € (-4,98 %)     ADYEN 845.200 € (-2,14 %)     ING GROEP N.V. 22.945 € (-1,25 %)     WOLTERS KLUWER 65.320 € (+0,37 %)     KERING 265.250 € (+0,78 %)     KPN KON 4.848 € (+1,66 %)     STELLANTIS NV 6.574 € (+3,97 %)     Vusion 108.700 € (-2,16 %)     ALLFUNDS GROUP 8.600 € (+0,58 %)     THEON INTERNAT 34.000 € (+1,49 %)     ROBERTET 815.000 € (+0,25 %)     ASML HOLDING 1 161.000 € (-2,24 %)     NSE 49.500 € (-0,80 %)     TOUAX 3.940 € (0,00 %)     BNP PARIBAS ACT.A 83.300 € (-2,44 %)     FORVIA 9.944 € (-2,27 %)     KALRAY 3.405 € (-2,71 %)     POXEL 0.281 € (-11,91 %)     EXAIL TECHNOLOGIES 133.000 € (+1,53 %)     RUBIS 35.060 € (+0,57 %)     ORANGE 17.890 € (+1,22 %)     ASR NEDERLAND 60.920 € (+0,33 %)     AIRBUS 165.140 € (-1,64 %)     BOIRON 28.000 € (+1,08 %)     PLANISWARE 14.580 € (-0,82 %)     ARCELORMITTAL SA 45.660 € (-2,14 %)     PHILIPS KON 23.580 € (-0,08 %)     NOVACYT 0.373 € (-1,84 %)     ENGIE 28.970 € (+2,01 %)     STMICROELECTRONICS 29.085 € (-2,84 %)     BE SEMICONDUCTOR 190.150 € (+1,39 %)     WORLDLINE 0.289 € (+6,10 %)     DSM FIRMENICH AG 61.420 € (+1,12 %)     EIFFAGE 135.700 € (-0,33 %)     HEINEKEN HOLDING 62.850 € (+0,24 %)     2CRSI 28.700 € (-2,21 %)     SCHNEIDER ELECTRIC 236.150 € (-1,58 %)     FNAC DARTY 35.250 € (0,00 %)     SHELL PLC 40.605 € (+2,73 %)     LATECOERE 0.021 € (+5,05 %)     ALUMEXX N.V. 1.440 € (-1,37 %)     VINCI 131.600 € (-0,75 %)     NANOBIOTIX 27.400 € (-5,35 %)     PROSUS 40.020 € (-1,26 %)     FRANCAISE ENERGIE 41.050 € (+7,74 %)     INPOST 15.130 € (+0,07 %)     SAFRAN 287.300 € (-1,14 %)     AALBERTS NV 30.020 € (-2,09 %)     NEOVACS 0.001 € (-16,67 %)     ALPES (COMPAGNIE) 24.700 € (+1,23 %)     EURONEXT 143.300 € (+2,07 %)     MAUREL ET PROM 10.920 € (+7,48 %)     AHOLD DEL 41.730 € (+1,29 %)     ALTAMIR 24.600 € (0,00 %)     LHYFE 2.490 € (-0,20 %)     TOTALENERGIES 79.420 € (+2,40 %)     ABC ARBITRAGE 5.300 € (-0,93 %)  
SARTORIUS STED BIO
DIM - FR0013154002 - Euronext Paris
169,100 €  17:35
+0,83 %
24/03/2026 15:32

Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.

Sartorius Stedim Biotech SA / Key word(s): AGM/EGM
Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.

24-March-2026 / 15:32 CET/CEST

Aubagne, France | March 24, 2026

Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.

At today’s combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A., shareholders granted discharge to all Directors by a large majority.
 
Effective March 24, 2026, the Board of Directors of Sartorius Stedim Biotech S.A. is composed of: Michael Grosse (Chairman), René Fáber (CEO), Pascale Boissel, Susan Dexter, Cécile Dussart, Abdelatif Zeroual (Director Representing Employees), Anne-Marie Graffin (Lead Independent Director), Lothar Kappich, and Christopher Nowers.
 
The shareholders also approved all other resolutions by a large majority, including the proposal to pay a dividend of 0.69 euros per share for fiscal 2025. The total payout will be 67.1 million euros. The dividend will be paid as from April 2, 2026.


Further Information
Shareholders' Meeting | Sartorius Stedim Biotech S.A.
Company images
CVs and images of the Directors


Financial calendar 
April 23, 2026 | Publication of the first quarter results for January to March 2026 
July 23, 2026 | Publication of half-year results for January to June 2026 
October 22, 2026 | Publication of nine-month results January to September 2026  


A profile of Sartorius Stedim Biotech 
Sartorius Stedim Biotech is a leading international partner of the biopharmaceutical industry. As a provider of innovative solutions, the company based in Aubagne, France, helps its customers to manufacture biotech medications, such as cell and gene therapies, safely, rapidly, and sustainably. The shares of Sartorius Stedim Biotech S.A. are quoted on the Euronext Paris. The company has a strong global reach with manufacturing and R&D sites as well as sales entities in Europe, North America, and Asia. Sartorius Stedim Biotech regularly expands its portfolio through acquisitions of complementary technologies. In 2025, the company generated sales revenue of around 3 billion euros. Currently, more than 10,200 employees are working for customers around the globe.  
 

Contact 
Verena Sattel
External Communications 
+49 551 308 9261
verena.sattel@sartorius.com
 
Attachment

File: Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A. | Media Release

Dissemination of a Financial Wire News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

View original content: EQS News

Language:English
Issuer:Sartorius Stedim Biotech SA
Avenue de Jouques
13781 Aubagne
France
Phone:+33 44 284 5600
E-mail:sartorius.presse@sartorius.com
Internet:www.sartorius.com
ISIN:FR0013154002
EQS News ID:2296728

 
End of Announcement - EQS News Service

2296728  24-March-2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière